AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults 65 and older could double to 1.7B by 2053.¹

Unique Care Needs Driving Demand

Older individuals, those 65 and older, make up 17% of the U.S. population and account for 37% of healthcare spending.^2,³ Nearly 70% of adults 65 and older will require long-term care in their lifetime.⁴

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

¹United Nations, Jul 2024
²Ibid
³Centers for Medicare & Medicaid Services, Sep 2024
⁴U.S. Department of Health and Human Services, Office of Disability Aging and Long-Term Care Policy, and Urban Institute, Apr 2019

Key Information As of 04/02/25

Inception Date	05/09/16
Total Expense Ratio	0.50%
Net Assets	$58.14 million
NAV	$31.09
Fact Sheet	View the document

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 04/01/25

Ticker	AGNG
Bloomberg Index Ticker	ILNGRNT
CUSIP	37954Y772
ISIN	US37954Y7720
Primary Exchange	Nasdaq
Shares Outstanding	1,870,000
Number of Holdings	82
30-Day Median Bid-Ask Spread	0.35%

Distributions As of 04/02/25

30-Day SEC Yield	0.65%
Distribution Frequency	Semi-Annually

ETF Prices As of 04/02/25

NAV	$31.09	Daily Change	-$0.03	-0.10%
Market Price	$30.96	Daily Change	-$0.14	-0.45%

As of recent month & quarter-end (03/31/25) As of recent month & quarter-end (03/31/25)	Fund NAV	Market Price	Index
1 Year	5.41%	4.82%	5.82%
3 Years	3.80%	3.78%	4.12%
5 Years	9.87%	9.87%	10.17%
Since Inception	9.27%	9.52%	9.57%
1 Year	5.41%	4.82%	5.82%
3 Years	3.80%	3.78%	4.12%
5 Years	9.87%	9.87%	10.17%
Since Inception	9.27%	9.52%	9.57%
Year-to-Date	3.71%	3.68%	3.77%
1 Month	-3.03%	-3.04%	-2.99%
3 Months	3.71%	3.68%	3.77%
Since Inception	120.05%	124.55%	125.52%
Year-to-Date	3.71%	3.68%	3.77%
1 Month	-3.03%	-3.04%	-2.99%
3 Months	3.71%	3.68%	3.77%
Since Inception	120.05%	124.55%	125.52%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
4.80	WELL	WELLTOWER INC	BYVYHH4	153.08	18,233	2,791,107.64
4.12	BSX	BOSTON SCIENTIFIC CORP	2113434	100.05	23,938	2,394,996.90
3.65	4519 JP	CHUGAI PHARMA CO	6196408	43.98	48,243	2,121,757.59
3.47	ABBV	ABBVIE INC	B92SR70	205.19	9,836	2,018,248.84
3.44	BMY	BRISTOL-MYERS SQUIBB CO	2126335	59.60	33,550	1,999,580.00
3.21	AMGN	AMGEN INC	2023607	305.70	6,102	1,865,381.40
3.20	ALC SW	ALCON INC	BJT1GR5	92.68	20,063	1,859,525.29
3.13	RO SW	ROCHE HOLDING AG-BR	7108918	343.40	5,304	1,821,399.67
3.09	SYK	STRYKER CORP	2853688	377.46	4,757	1,795,577.22
3.06	MDT	MEDTRONIC PLC	BTN1Y11	88.86	20,047	1,781,376.42
3.05	LLY	ELI LILLY & CO	2516152	818.22	2,169	1,774,719.18
2.96	JNJ	JOHNSON & JOHNSON	2475833	155.36	11,071	1,719,990.56
2.95	UCB BB	UCB SA	5596991	176.63	9,700	1,713,356.71
2.95	AZN	ASTRAZENECA PLC-SPONS ADR	2989044	72.22	23,719	1,712,986.18
2.39	VTR	VENTAS INC	2927925	69.39	20,030	1,389,881.70
2.34	4543 JP	TERUMO CORP	6885074	18.34	74,307	1,363,060.11
2.26	068270 KS	CELLTRION INC	B0C5YV1	115.71	11,349	1,313,145.81
2.25	ONC	BEIGENE LTD-ADR	BYYWPW6	274.78	4,760	1,307,952.80
2.23	EW	EDWARDS LIFESCIENCES CORP	2567116	72.05	18,024	1,298,629.20
1.98	ZBH	ZIMMER BIOMET HO	2783815	112.50	10,208	1,148,400.00
1.93	REGN	REGENERON PHARMACEUTICALS	2730190	625.60	1,790	1,119,824.00
1.63	STMN SW	STRAUMANN HOLDING AG-REG	BQ7ZV06	119.68	7,900	945,475.15
1.61	PODD	INSULET CORP	B1XGNW4	269.13	3,486	938,187.18
1.60	3692 HK	HANSOH PHARMACEU	BJYKB72	3.14	295,443	928,236.31
1.54	NOVOB DC	NOVO NORDISK A/S-B	BP6KMJ1	67.89	13,208	896,741.04
1.51	SDZ SW	SANDOZ GROUP AG	BLPLD38	41.04	21,457	880,555.30
1.45	SOON SW	SONOVA HOLDING AG-REG	7156036	285.71	2,953	843,714.29
1.45	4503 JP	ASTELLAS PHARMA INC	6985383	9.38	89,909	843,093.91
1.38	DXCM	DEXCOM INC	B0796X4	68.14	11,756	801,053.84
1.26	UTHR	UNITED THERAPEUTICS CORP	2430412	312.26	2,343	731,625.18
1.24	FME GR	FRESENIUS MEDICAL CARE AG	5129074	49.47	14,612	722,898.29
1.19	INCY	INCYTE CORP	2471950	62.33	11,128	693,608.24
1.15	DVA	DAVITA INC	2898087	154.29	4,348	670,852.92
1.05	GMAB DC	GENMAB A/S	4595739	185.59	3,282	609,122.01
1.04	SN/ LN	SMITH & NEPHEW PLC	0922320	13.94	43,540	606,854.84
0.96	EXEL	EXELIXIS INC	2576941	37.04	15,016	556,192.64
0.94	COH AU	COCHLEAR LTD	6211798	168.86	3,250	548,780.03
0.92	NBIX	NEUROCRINE BIOSC	2623911	108.31	4,933	534,293.23
0.82	PHM SM	PHARMA MAR SA	BMW2GT8	86.25	5,536	477,505.62
0.79	OHI	OMEGA HEALTHCARE	2043274	37.88	12,149	460,204.12
0.69	EXAS	EXACT SCIENCES CORP	2719951	44.56	8,993	400,728.08
0.68	HALO	HALOZYME THERAPEUTICS INC	2975098	63.02	6,297	396,836.94
0.64	ENSG	ENSIGN GROUP INC/THE	B1YWPP8	132.25	2,807	371,225.75
0.63	DEMANT DC	DEMANT A/S	BZ01RF1	32.97	11,116	366,516.64
0.57	TFX	TELEFLEX INC	2881407	141.38	2,335	330,122.30
0.53	MMSI	MERIT MEDICAL SYSTEMS INC	2580555	107.04	2,876	307,847.04
0.47	BPMC	BLUEPRINT MEDICINES CORP	BWY52P3	90.01	3,037	273,360.37
0.45	YPSN SW	YPSOMED HOLDING AG-REG	B02SWN8	383.63	675	258,953.36
0.42	GKOS	GLAUKOS CORP	BYMWL19	100.04	2,452	245,298.08
0.39	AMP IM	AMPLIFON SPA	B14NJ71	20.07	11,240	225,566.33
0.38	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	1.05	211,902	222,738.01
0.36	CSH-U CN	CHARTWELL RETIRE	B8S8C94	11.80	17,889	211,054.57
0.36	NVCR	NOVOCURE LTD	BYSS4X4	17.94	11,614	208,355.16
0.36	SBRA	SABRA HEALTH CAR	B5NLBP6	17.36	11,896	206,514.56
0.35	NHI	NATL HEALTH INVESTORS INC	2626125	73.77	2,784	205,375.68
0.35	ITGR	INTEGER HOLDINGS CORP	BD06LM7	121.08	1,658	200,750.64
0.34	SIA CN	SIENNA SENIOR LIVING INC	BWTYXH4	11.69	16,902	197,519.79
0.33	1789 HK	AK MEDICAL HOLDINGS LTD	BFD6SZ0	0.80	239,289	191,565.26
0.33	MNKD	MANNKIND CORP	BF081J4	5.02	38,140	191,462.80
0.32	EMBC	EMBECTA CORP	BMXWYR1	12.52	14,896	186,497.92
0.31	LTC	LTC PROPERTIES INC	2498788	35.32	5,094	179,920.08
0.31	8086 JP	NIPRO CORP	6641599	8.91	19,900	177,235.93
0.30	AED BB	AEDIFICA	B1G5XP1	66.55	2,633	175,226.52
0.29	NHC	NATIONAL HEALTHCARE CORP	2139731	93.75	1,825	171,093.75
0.28	TBPH	THERAVANCE BIOPHARMA INC	BMNDK09	9.01	18,345	165,288.45
0.28	AMED	AMEDISYS INC	2024332	92.98	1,774	164,946.52
0.27	ACAD	ACADIA PHARMACEU	2713317	16.62	9,419	156,543.78
0.26	AGIO	AGIOS PHARMACEUTICALS INC	BCBVTX1	28.44	5,356	152,324.64
0.26	1302 HK	LIFETECH SCIENTIFIC CORP	BV9FKS0	0.21	719,092	151,542.44
0.26	BKD	BROOKDALE SR	B0PZN33	6.04	24,602	148,596.08
0.24		OTHER PAYABLE & RECEIVABLES		1.00	141,948	141,947.59
0.22	2186 HK	LUYE PHARMA GROUP LTD	BNQ4GF3	0.28	455,824	127,690.82
0.22	AGL	AGILON HEALTH INC	BLR4TK4	4.07	30,766	125,217.62
0.22	RYM NZ	RYMAN HEALTHCARE LTD	6161525	1.53	81,392	124,750.51
0.21	ATEC	ALPHATEC HOLDINGS INC	BD60BG7	10.45	11,691	122,170.95
0.21	LIVN	LIVANOVA PLC	BYMT0J1	39.50	3,032	119,764.00
0.20	GN DC	GN STORE NORD A/S	4501093	15.79	7,491	118,264.61
0.20	EKTAB SS	ELEKTA AB-B SHS	B0M42T2	5.27	22,429	118,211.85
0.20	DNLI	DENALI THERAPEUTICS INC	BD2B4V0	13.74	8,558	117,586.92
0.16	145720 KS	DENTIUM CO LTD	BF07GJ6	52.91	1,738	91,957.04
0.07	9229 JP	SUNWELS CO LTD	BNTYNB5	3.76	10,294	38,707.78
0.05	ALEC	ALECTOR INC	BJ4LDC4	1.18	26,256	30,982.08
0.04		CASH		1.00	25,085	25,084.54
0.00		RADIUS HEALTH INC - CVR	2KFF9T0	0.00	19,104	0.02
0.00		DANISH KRONE		0.15	-997	-145.14

Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 03/31/25

	Sector	Weight (%)
	Health Care	90.6
	Real Estate	9.4

Source: new windowAltaVista Research, LLC

	Industry	Weight (%)
	Pharmaceuticals, Biotechnology & Life Sciences	47.3
	Health Care Equipment & Services	39.4
	Equity Real Estate Investment Trusts (REITs)	9.4
	Pharmaceuticals, Biotechnology	3.9

Source: new windowAltaVista Research, LLC

	Country	Weight (%)
	United States	53.7
	Switzerland	11.5
	Japan	8.1
	China	5.0
	Britain	4.6
	Denmark	3.5
	Belgium	3.3
	Ireland	3.1
	South Korea	2.5
	Germany	1.3
	Australia	0.9
	Other	2.5

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 04/02/25

Return on Equity	14.70%
Weighted Avg. Market Cap	101,544 M
	2024	2025
Price-to-earnings	27.64	21.80
Price-to-book value	3.37	3.05

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 03/31/25

Versus	Beta
S&P 500	0.68
NASDAQ-100	0.45
MSCI EAFE	0.74
MSCI Emg. Mkts	0.51
Standard Deviation	14.80%

Source: new windowAltaVista Research, LLC

ETF Research

ETF Documents

Latest Premium / Discount As of 04/02/25

NAV	$31.09
Market Price	$30.96
Premium / (Discount)	($0.13)

Current View 2025 Q2 As of 04/02/25

Days at Premium	0
Days at NAV	0
Days at Discount	2
Greatest Premium	0.00%
Greatest Discount	-0.43%

Daily Premium / Discount History As of 04/02/25

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Unique Care Needs Driving Demand

Unconstrained Approach

Key Information As of 04/02/25

ETF Summary

ETF Objective

Trading Details As of 04/01/25

Distributions As of 04/02/25

ETF Prices As of 04/02/25

Performance History

Top Holdings As of 04/02/25

Exposure As of 03/31/25

ETF Characteristics As of 04/02/25

ETF Risk Stats As of 03/31/25

ETF Research

Investing in Pharma: How to Spot Leading Drug Candidates

Investing in Pharma: The Drug Lifecycle

In the Pipeline: Top Drug Candidates for FDA Approval in 2024

ETF Documents